» Articles » PMID: 36185220

The Value of Narrow-band Imaging Bronchoscopy in Diagnosing Central Lung Cancer

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Oct 3
PMID 36185220
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: This research aimed to study the value of narrow-band imaging(NBI) in the diagnosis of central lung cancer.

Materials And Methods: This study included 916 patients with clinical suspected of central lung cancer or follow-up of patients after curative lung cancer surgery. All of the patients were examined by Olympus Evis Lucera electronic bronchoscope system, any sites that were abnormal when viewed by white-light bronchoscopy (WLB) or NBI were biopsied, four to six biopsies were taken at each site of the abnormal region visualized as lesions, we record the endoscopic features of NBI and compared with histopathology results, to evaluate the diagnostic value of NBI for central lung cancer and the relationship between vascular patterns of NBI and histological types of lung cancer, and try to establish a multinomial logistic regression model for predicting the histological types of lung cancer. The biopsy specimens were examined by CD34 antibody through immunohistochemistry (IHC) method, CD34 marked microvessel density(MVD), compared the number of microvessels between benign and malignant diseases and the number between different histological types of lung cancer, to verify the results of NBI.

Results: NBI provided high sensitivity (91.7%), specificity (84.9%), positive predictive value (97.6%), negative predictive value (61.5%), and agreement rate (90.7%). The predominant vascular patterns in the well-defined histological types of lung cancer were dotted blood vessels (121 patients), tortuous blood vessels (248 patients), and abrupt-ending blood vessels (227 patients). Logistic regression analysis of the results showed that smoking status of the patient, combined with vascular patterns under NBI, and age partly affect the histological types of lung cancer.

Conclusions: NBI is highly accurate for the diagnosis of central lung cancer.

Citing Articles

A Deceptive Tracheal Mass Mimicking Asthma.

Saini J, Shastry S, V V, Srivastava A, A S J Brown Hosp Med. 2025; 3(1):91419.

PMID: 40027395 PMC: 11864405. DOI: 10.56305/001c.91419.


The insufficiency of CT examination in early detection of central lung squamous cell carcinoma and squamous epithelial precancerous lesions.

Zhou J, Yu B, Guo P, Wang S BMC Cancer. 2024; 24(1):299.

PMID: 38443800 PMC: 10916110. DOI: 10.1186/s12885-024-12052-9.

References
1.
Ning J, Ge T, Jiang M, Jia K, Wang L, Li W . Early diagnosis of lung cancer: which is the optimal choice?. Aging (Albany NY). 2021; 13(4):6214-6227. PMC: 7950268. DOI: 10.18632/aging.202504. View

2.
Boscolo Nata F, Tirelli G, Capriotti V, Marcuzzo A, Sacchet E, Suran-Brunelli A . NBI utility in oncologic surgery: An organ by organ review. Surg Oncol. 2020; 36:65-75. DOI: 10.1016/j.suronc.2020.11.017. View

3.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

4.
Andolfi M, Potenza R, Capozzi R, Liparulo V, Puma F, Yasufuku K . The role of bronchoscopy in the diagnosis of early lung cancer: a review. J Thorac Dis. 2017; 8(11):3329-3337. PMC: 5179455. DOI: 10.21037/jtd.2016.11.81. View

5.
Becker N, Motsch E, Trotter A, Heussel C, Dienemann H, Schnabel P . Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial. Int J Cancer. 2019; 146(6):1503-1513. DOI: 10.1002/ijc.32486. View